[Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2

[已撤稿] MicroRNA-155 通过靶向 ARID2 促进人肝细胞癌的肿瘤生长

阅读:1

Abstract

Following the publication of the above paper, a concerned reader drew to the Editor's attention that, in addition to concerns about the description of one of the antibodies employed in this study, the immunohistochemical data shown in Fig. 4E on p. 2429 and western blot data shown in Fig. 6E on p. 2431 had apparently appeared in figures in other papers that had already been submitted to the journals Oncotarget and International Journal of Oncology respectively, both of which were written by different authors at different research institutes. Upon performing an independent analysis of the data in the Editorial Office, we were able to validate these concerns; moreover, some of the same western blot data had also apparently been included in Figs. 4 and 5. Given that the abovementioned data had already been submitted for publication to other journals, the Editor of International Journal of Oncology has decided that this article should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 48: 2425‑2434, 2016; DOI: 10.3892/ijo.2016.3465].

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。